Communications in Humanities Research ISSN: 2753-7072
Home> Volumes> Volume CHR Vol.56> Article
Research Article

Gonadal Hormone Contribution to Substance Use Disorders and Neurodegenerative Diseases in Female

Michelle TianTsinghua International School*

* Corresponding author: [email protected]

Abstract

Sex differences have been long recognized to influence multiple systems in the human body, ranging from the cardiovascular system to the neurological system, and these differences have been attributed primarily to the influence of the gonadal hormone, estrogen. In most cases, estrogen functions as a protective agent against multiple diseases, e.g., neurodegenerative diseases, thereby making women generally less vulnerable than men. However, research studies have also shown that estrogen contributes to increased vulnerability in developing substance use disorders (SUD), where because women have higher concentration of circulating estrogen, setting them at a higher risk for development of SUD. While extensive research has revealed some of the underlying mechanisms through which estrogen influences both substance use disorders (SUD) and neurodegenerative diseases, current studies have yet to investigate situations in which these diseases coexist. Such investigations could potentially illuminate the nuanced relationship between the two conditions. In this comprehensive review paper, the mechanisms underlying gender-dependent vulnerability are discussed, along with more real-life dilemmas and questions that are posed. To address these questions, some potential preclinical and clinical experimental proposals are explored and discussed

Keywords: Estrogen; neurotransmitter; menopause; substance use disorders (SUDs)
Published: March 31, 2025
DOI: 10.54254/2753-7064/2024.21649
Volume: CHR Vol.56
pp. 129-136
Download PDF

References

  1. Brady, K.T.; Randall, C.L. Gender differences in substance use disorders. Psychiatr. Clin. N. Am. 1999, 22, 241–252. doi:10.1016/S0193-953X(05)70074-5. [PubMed: 10385931]
  2. Russell, J. K., Jones, C. K., and Newhouse, P. A. (2019). The role of estrogen in brain and cognitive aging. Neurotherapeutics 16, 649–665. doi: 10.1007/s13311-019-00766-9.
  3. Bendis, P.C.; Zimmerman, S., Onisiforou, A.; Zanos, P.; Georgiou, P. (2024). The impact of estradiol on serotonin, glutamate, and dopamine systems. Frontiers in Neuroscience 22 March 2024. 10.3389/fnins.2024.1348551
  4. Hwang, W. J., Lee, T. Y., Kim, N. S., and Kwon, J. S. (2021). The role of estrogen receptors and their signaling across psychiatric disorders. Int. J. Mol. Sci. 22:373. doi: 10.3390/ijms22010373
  5. Annis HM, Graham JM. Profile types on the Inventory of Drinking Situations: Implications for relapse prevention counseling. Psychol Addict Behav 1995;9(3):176–182. doi:10.1037/0893-164X.9.3.176.
  6. Baldwin, D., and Rudge, S. (1995). The role of serotonin in depression and anxiety. Int. Clin. Psychopharmacol. 9, 41–46. doi: 10.1097/00004850-199501004-00006
  7. Hernández-Hernández, O. T., Martínez-Mota, L., Herrera-Pérez, J. J., and Jiménez-Rubio, G. (2019). Role of estradiol in the expression of genes involved in serotonin neurotransmission: implications for female depression. Curr. Neuropharmacol.17, 459–471. doi: 10.2174/1570159X16666180628165107
  8. Quello, S. B., Brady, K. T., & Sonne, S. C. (2005). Mood disorders and substance use disorder: a complex comorbidity. Science & practice perspectives, 3(1), 13–21. https://doi.org/10.1151/spp053113
  9. Björnström, L., and Sjöberg, M. (2005). Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 19, 833–842. doi: 10.1210/me.2004-0486
  10. Le Dily, F., and Beato, M. (2018). Signaling by steroid hormones in the 3D nuclear space. Int. J. Mol. Sci. 19:306. doi: 10.3390/ijms19020306
  11. Kanova, M., and Kohout, P. (2021). Serotonin—its synthesis and roles in the healthy and the critically ill. Int. J. Mol. Sci. 22:4837. doi: 10.3390/ijms22094837
  12. Bertrand, P. P., Paranavitane, U. T., Chavez, C., Gogos, A., Jones, M., and van den Buuse, M. (2005). The effect of low estrogen state on serotonin transporter function in mouse hippocampus: a behavioral and electrochemical study. Brain Res. 1064, 10–20. doi: 10.1016/j.brainres.2005.10.018
  13. Bethea, C. L., Smith, A. W., Centeno, M. L., and Reddy, A. P. (2011). Long-term ovariectomy decreases serotonin neuron number and gene expression in free ranging macaques. Neuroscience 192, 675–688. doi: 10.1016/j.neuroscience.2011.06.003
  14. McQueen, J. K., Wilson, H., and Fink, G. (1997). Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Brain Res. Mol. Brain Res. 45, 13–23. doi: 10.1016/s0169-328x(96)00233-1
  15. Ford C.P., The Role of D2-Autoreceptors in Regulating Dopamine Neuron Activity and Transmission. Neuroscience. 2014 Dec 12; 282: 13–22. doi: 10.1016/j.neuroscience.2014.01.02
  16. Jewett B.E., Thapa B., Physiology, NMDA Receptor. StatPearls [Internet], 2022/12/11
  17. Weiland, N. G. (1992). Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology 131, 662–668. doi: 10.1210/endo.131.2.1353442
  18. Foy, M. R., Xu, J., Xie, X., Brinton, R. D., Thompson, R. F., and Berger, T. W. (1999). 17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J. Neurophysiol. 81, 925–929. doi: 10.1152/jn.1999.81.2.925
  19. Woolley, C. S., and McEwen, B. S. (1994). Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J. Neurosci.14, 7680–7687. doi: 10.1523/JNEUROSCI.14-12-07680.1994
  20. Yap, S., Luki, J., Hanstock, C. C., Seres, P., Shandro, T., Hanstock, S. E. C. et al (2021). Decreased Medial Prefrontal Cortex Glutamate Levels in Perimenopausal Women. Front. Psychiatry 12:763562. doi: 10.3389/fpsyt.2021.763562
  21. Quigley, J. A., Logsdon, M. K., Turner, C. A., Gonzalez, I. L., Leonardo, N. B., & Becker, J. B. (2021). Sex differences in vulnerability to addiction. Neuropharmacology, 187, 108491. https://doi.org/10.1016/j.neuropharm.2021.108491
  22. Schultz W Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey. J. Neurophysiol 1986;56(5):1439–1461. doi:10.1152/jn.1986.56.5.1439. [PubMed: 3794777]
  23. Everitt BJ, Parkinson JA, Olmstead MC, Arroyo M, Robledo P, Robbins TW. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann. N. Y. Acad. Sci 1999;877:412–438. doi:10.1111/j.1749-6632.1999.tb09280.x. [PubMed: 10415662]
  24. Wise RA, Rompre PP. Brain dopamine and reward. Annu. Rev. Psychol 1989;40:191–225. doi:10.1146/annurev.ps.40.020189.001203. [PubMed: 2648975]
  25. Robinson MJF, Fischer AM, Ahuja A, Lesser EN, Maniates H. Roles of “wanting” and “liking” in motivating behavior: gambling, food, and drug addictions. Current topics in behavioral neurosciences 2016;27:105–136. doi:10.1007/7854_2015_387. [PubMed: 26407959]
  26. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993;18(3):247–291. doi:10.1016/0165-0173(93)90013-P. [PubMed: 8401595]
  27. Kawa AB, Robinson TE. Sex differences in incentive-sensitization produced by intermittent access cocaine self-administration. Psychopharmacology 2019;236(2):625–639. doi:10.1007/s00213-018-5091-5. [PubMed: 30368583]
  28. Becker JB, Molenda H, Hummer DL. Gender differences in the behavioral responses to cocaine and amphetamine. Implications for mechanisms mediating gender differences in drug abuse. Ann. N. Y. Acad. Sci 2001;937:172–187. [PubMed: 11458536]
  29. Becker JB. Sex differences in addiction. Dialogues Clin Neurosci 2016;18(4):395–402. [PubMed: 28179811]
  30. Becker JB, Perry AN, Westenbroek C. Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis. Biol. Sex Differ 2012;3(1):14. doi:10.1186/2042-6410-3-14. [PubMed: 22676718]
  31. Ruda-Kucerova J, Amchova P, Babinska Z, Dusek L, Micale V, Sulcova A. Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats. Front. Psychiatry 2015;6:91. doi:10.3389/fpsyt.2015.00091. [PubMed: 26217239]
  32. Creutz LM, Kritzer MF. Estrogen receptor-beta immunoreactivity in the midbrain of adult rats: regional, subregional, and cellular localization in the A10, A9, and A8 dopamine cell groups. J. Comp. Neurol 2002;446(3):288–300. doi:10.1002/cne.10207. [PubMed: 11932944]
  33. Kritzer MF, Creutz LM. Region and sex differences in constituent dopamine neurons and immunoreactivity for intracellular estrogen and androgen receptors in mesocortical projections in rats. J. Neurosci 2008;28(38):9525–9535. doi:10.1523/JNEUROSCI.2637-08.2008. [PubMed: 18799684]
  34. Küppers E, Krust A, Chambon P, Beyer C. Functional alterations of the nigrostriatal dopamine system in estrogen receptor-alpha knockout (ERKO) mice. Psychoneuroendocrinology 2008;33(6):832–838. doi:10.1016/j.psyneuen.2008.03.007. [PubMed: 18472350]
  35. Le Saux M, Morissette M, Di Paolo T. ERbeta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens. Neuropharmacology 2006;50(4):451–457. doi:10.1016/j.neuropharm.2005.10.004. [PubMed: 16309717]
  36. Iwasaki-Sekino A, Mano-Otagiri A, Ohata H, Yamauchi N, Shibasaki T. Gender differences in corticotropin and corticosterone secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats. Psychoneuroendocrinology 2009;34(2):226–237. doi:10.1016/j.psyneuen.2008.09.003. [PubMed: 18849120]
  37. Yoest KE, Cummings JA, Becker JB. Oestradiol influences on dopamine release from the nucleus accumbens shell: sex differences and the role of selective oestradiol receptor subtypes. Br. J. Pharmacol 2019;176(21):4136–4148. doi:10.1111/bph.14531. [PubMed: 30381823]
  38. Yoest KE, Cummings JA, Becker JB. Oestradiol influences on dopamine release from the nucleus accumbens shell: sex differences and the role of selective oestradiol receptor subtypes. Br. J. Pharmacol 2019;176(21):4136–4148. doi:10.1111/bph.14531. [PubMed: 30381823]
  39. Cummings JA, Jagannathan L, Jackson LR, Becker JB. Sex differences in the effects of estradiol in the nucleus accumbens and striatum on the response to cocaine: neurochemistry and behavior. Drug Alcohol Depend. 2014;135:22–28. doi:10.1016/j.drugalcdep.2013.09.009. [PubMed: 24332790]
  40. Yoest KE, Cummings JA, Becker JB. Ovarian hormones mediate changes in adaptive choice and motivation in female rats. Front. Behav. Neurosci 2019;13:250. doi:10.3389/fnbeh.2019.00250. [PubMed: 31780908]
  41. Yoest KE, Quigley JA, Becker JB. Rapid effects of ovarian hormones in dorsal striatum and nucleus accumbens. Horm. Behav 2018;104:119–129. doi:10.1016/j.yhbeh.2018.04.002. [PubMed: 29626485]
  42. Beery A. K. and Zucker I., Sex bias in neuroscience and biomedical research. Neuroscience and Biobehavioral Reviews, vol. 35, no. 3, pp. 565–572, 2011.
  43. Davies W., Sex differences in Attention Deficit Hyperactivity Disorder: candidate genetic and endocrine mechanisms. Frontiers in Neuroendocrinology, vol. 35, no. 3, pp. 331–346, 2014
  44. Schaafsma S. M. and Pfaff D. W., Etiologies underlying sex differences in autism spectrum disorders,” Frontiers in Neuroendocrinology, vol. 35, no. 3, pp. 255–271, 2014
  45. Bustamante-Barrientos FA, Mendez-Ruette M, Ortloff A, Luz-Crawford P, Rivera FJ, Figueroa CD, et al. The impact of estrogen and estrogen-like molecules in neurogenesis and neurodegeneration: Beneficial or harmful? Front Cell Neurosci (2021) 15:636176. doi: 10.3389/fncel.2021.636176
  46. Al Sweidi S, Sanchez MG, Bourque M, Morissette M, Dluzen D, Di Paolo T. Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in parkinson's disease. J Neuroendocrinol (2012) 24(1):48–61. doi: 10.1111/j.1365-2826.2011.02193.x
  47. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen recepor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol 1997;388(4):507-525.doi:10.1002/(sici)1096-9861(19971201)388:4<507::aid-cne1>3.0.co;2-6. [PubMed: 9388012]
  48. Chen P, Li B and Ou-Yang L (2022) Role of estrogen receptors in health and disease. Front. Endocrinol. 13:839005. doi: 10.3389/fendo.2022.839005
  49. Maharjan, S., Serova, L., and Sabban, E. L. (2005). Transcriptional regulation of tyrosine hydroxylase by estrogen: opposite effects with estrogen receptors alpha and beta and interactions with cyclic AMP. J. Neurochem. 93, 1502–1514. doi: 10.1111/j.1471-4159.2005.03142.x
  50. Gipson C.D., Bimonte-nelson H.A., Interactions between Reproductive Transitions during Aging and Addiction: Promoting Translational Crosstalk between Different Fields of Research. Behav Pharmacol. 2021 April 01; 32(2-#x000263): 112–122. doi:10.1097/FBP.0000000000000591
  51. Konnova E.A., Swanberg M., Chapter 5 Animal Models of Parkinson’s Disease. Parkinson’s Disease: Pathogenesis and Clinical Aspects.